GlaxoSmithKline PLC
ISIN: GB00BN7SWP63 | Ticker: GSK | LEI: 5493000HZTVUYLO1D793
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.
Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
2000
Served areaWorldwide
Headcount69,400
HeadquartersC8 Gsk House, 980 Great West Road, TW8 9GS Brentford – United Kingdom
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | ENG | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
| Report | Q1 | H1 | Q3 | FY |
|---|---|---|---|---|
| Consolidated Report | ENG | |||
| Corporate Governance Report | ||||
| Company Presentation | ||||
| General Presentation | ||||
| Sustainability Report | ||||
| Remuneration Report |
2,001,000,000
IPOMay 22, 1972
Stock exchange(s)London Stock Exchange